Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives
Kristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Charlotte Wilhelmina Wernberg, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 673-673
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
Sara Montagnese, Pierre‐Emmanuel Rautou, Manuel Romero‐Gómez, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 807-824
Closed Access | Times Cited: 250
Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study
Céline Ben Hassen, Aurore Fayossé, Benjamin Landré, et al.
BMJ (2022), pp. e068005-e068005
Open Access | Times Cited: 76
Nonalcoholic Fatty Liver Disease and Risk of Dementia
Ying Shang, Linnea Widman, Hannes Hagström
Neurology (2022) Vol. 99, Iss. 6
Open Access | Times Cited: 49
Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction
Anna Hadjihambi, Christos Konstantinou, Jan Klohs, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 180-190
Open Access | Times Cited: 49
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
María Pilar Ballester, Thomas H. Tranah, Lorenz Balcar, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 4, pp. 967-976
Open Access | Times Cited: 27
Role of ammonia in NAFLD: An unusual suspect
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein Kerbert, et al.
JHEP Reports (2023) Vol. 5, Iss. 7, pp. 100780-100780
Open Access | Times Cited: 24
From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function
David Medina‐Julio, Mariana M. Ramírez-Mejía, Jacqueline Córdova‐Gallardo, et al.
Medical Science Monitor (2024) Vol. 30
Open Access | Times Cited: 14
Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study
Galit Weinstein, Adrienne O’Donnell, Kendra Davis‐Plourde, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 3, pp. 1371-1383
Closed Access | Times Cited: 30
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
Lorenz Balcar, Julia Krawanja, Bernhard Scheiner, et al.
JHEP Reports (2023) Vol. 5, Iss. 4, pp. 100682-100682
Open Access | Times Cited: 19
Non-alcoholic fatty liver disease causally affects the brain cortical structure: a Mendelian randomization study
Yu‐Kai Lin, Xinran Cai, Jiang-Zhi Chen, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma Biomarkers of Alzheimer Disease and Vascular Pathology
Yifei Lü, James Russell Pike, Ron C. Hoogeveen, et al.
Neurology (2024) Vol. 102, Iss. 7
Open Access | Times Cited: 6
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
Eda Kaya, Yusuf Yılmaz
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 25
Liver integrity and the risk of Alzheimer's disease and related dementias
Yifei Lü, James Russell Pike, Ron C. Hoogeveen, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 3, pp. 1913-1922
Open Access | Times Cited: 15
Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: The Cross‐Cohort Collaboration
Galit Weinstein, Adrienne O’Donnell, Stefan Frenzel, et al.
European Journal of Neurology (2023) Vol. 31, Iss. 1
Open Access | Times Cited: 13
Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines
Salvatore Pezzino, Tonia Luca, M. Castorina, et al.
Life (2024) Vol. 14, Iss. 1, pp. 93-93
Open Access | Times Cited: 5
A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach
Marica Meroni, Miriam Longo, Erika Paolini, et al.
Journal of Advanced Research (2024) Vol. 68, pp. 231-240
Open Access | Times Cited: 5
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment
Qiang Yu, Ruixin He, Haowen Jiang, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 21
The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review
Mauro Giuffrè, Nicola Merli, Maura Pugliatti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3337-3337
Open Access | Times Cited: 4
Non-alcoholic fatty liver disease is associated with structural covariance network reconfiguration in cognitively unimpaired adults with type 2 diabetes
Xin Li, Wen Zhang, Yan Bi, et al.
Neuroscience (2025) Vol. 568, pp. 58-67
Open Access
Early stage of metabolic dysfunction associated steatotic liver disease disrupts circadian rhythm and induces neuroinflammation in rats
Paul‐Henri Graindorge, Justine Paoli, Burak Oğulcan Yıldırım, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Normative Modeling Reveals Age‐Atypical Cortical Thickness Differences Between Hepatic Steatosis and Fibrosis in Non‐Alcoholic Fatty Liver Disease
Minchul Kim, Inpyeong Hwang, Kyu Sung Choi, et al.
Brain and Behavior (2025) Vol. 15, Iss. 4
Open Access
Sex differences in hepatic encephalopathy: addressing the knowledge gap
Lucia Lapenna, M. Merli, Marta Cilla, et al.
Digestive and Liver Disease (2025)
Open Access
The importance of patient engagement in the multimodal treatment of MASLD
Joost Boeckmans, Hannes Hagström, Donna R. Cryer, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
The prevalence and risk factors for cognitive impairment in obesity and NAFLD
Charlotte Wilhelmina Wernberg, Lea Ladegaard Grønkjær, Birgitte Gade Jacobsen, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 10
A Correlative Relationship Between Heart Failure and Cognitive Impairment: A Narrative Review
Myung Soo Park, Eung Ju Kim
Journal of Korean Medical Science (2023) Vol. 38, Iss. 39
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top